Concepedia

Antonio Passaro

AP

Statistics

Publications

45

Citations

4.6K

H-Index

24

Active since

2013

Affiliations

European Institute of Oncology(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Samsung Medical Center

Sungkyunkwan University

Yonsei University

Antonio Passaro is an author at European Institute of Oncology specializing in medicine, oncology, and lung cancer.

ORCID

Top concepts

Publications per year

2013–2025

45

Publications

45

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Lizza Hendriks, Keith M. Kerr, Jessica Menis et al. · Annals of Oncology · 2023 · 694 citations · Full text

, , +5

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Marina Chiara Garassino, Jennifer G. Whisenant, Li‐Ching Huang et al. · The Lancet Oncology · 2020 · 621 citations · Full text

, , +12

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Lizza Hendriks, Keith M. Kerr, Jessica Menis et al. · Annals of Oncology · 2023 · 524 citations · Full text

, , +4

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Antonio Passaro, Jing Wang, Yan Wang et al. · Annals of Oncology · 2023 · 347 citations · Full text

Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i> -Mutated Advanced NSCLC

Byoung Chul Cho, Shun Lu, Enriqueta Felip et al. · New England Journal of Medicine · 2024 · 308 citations · Full text

1–5 of 45